Acquired resistance to crizotinib in novel CDK14-ALK and CLTC-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing.
Journal Information
Full Title: Cancer Biol Ther
Abbreviation: Cancer Biol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"data availability statement the data that support the findings of this study are openly available in [repository name e g "figshare"] at http://doi org/ [doi] reference number [reference number]. data availability statement the data that support the findings of this study are openly available in [repository name e g "figshare"
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure statement No potential conflict of interest was reported by the author(s)."
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025